{"title":"Designer antiandrogens join the race against drug resistance","author":[{"surname":"Josan","given-names":"Jatinder S"},{"surname":"Katzenellenbogen","given-names":"John A"}],"abstract":"By using in silico models of the complexes formed by analogues of a cancer drug and its receptor, it may be possible to strategically redesign existing drugs and win the race against mutations that lead to drug resistance in prostate cancer.","identifier":[{"type":"publisher-id","id":"00692"},{"type":"doi","id":"10.7554/eLife.00692"}],"date":{"day":"09","month":"04","year":"2013"},"license":"http://creativecommons.org/licenses/by/3.0/","path":"00692","entryfile":"elife-00692-v1.xml","files":["elife-00692-fig1-v1-600w.jpg"]}